siRNA, Anti-RPL7L1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT71702WQ-2OMe)

The product SIRGT71702WQ-2OMe is a type of small interfering RNA (siRNA) that targets RPL7L1 gene and regulates the expression of gene. The siRNA interferes with the expression of RPL7L1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_198486.3
Alternative Names dJ475N16.4
Related Diseases Charcot-Marie-Tooth Disease
Purification HPLC
Target Gene
Gene ID 285855
Uniprot ID Q6DKI1
Sub Cat Target Species Modification Scale  
SIRGT72702WQ-2F RPL7L1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT73702WQ-2MOE RPL7L1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT74702WQ-LNA RPL7L1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT71702WQ-RB RPL7L1 Human Ribo-modified Inquiry
SIRGT72702WQ-BB RPL7L1 Human Backbone-modified Inquiry

Related Products